Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

References for PMC Articles for PubMed (Select 22720164)

1.

Directed evolution of hydrolases for prevention of G-type nerve agent intoxication.

Gupta RD, Goldsmith M, Ashani Y, Simo Y, Mullokandov G, Bar H, Ben-David M, Leader H, Margalit R, Silman I, Sussman JL, Tawfik DS.

Nat Chem Biol. 2011 Feb;7(2):120-5. doi: 10.1038/nchembio.510. Epub 2011 Jan 9.

PMID:
21217689
2.

Human PON1, a biomarker of risk of disease and exposure.

Furlong CE, Suzuki SM, Stevens RC, Marsillach J, Richter RJ, Jarvik GP, Checkoway H, Samii A, Costa LG, Griffith A, Roberts JW, Yearout D, Zabetian CP.

Chem Biol Interact. 2010 Sep 6;187(1-3):355-61. doi: 10.1016/j.cbi.2010.03.033. Epub 2010 Mar 23. Review.

3.

Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers.

Ashani Y, Gupta RD, Goldsmith M, Silman I, Sussman JL, Tawfik DS, Leader H.

Chem Biol Interact. 2010 Sep 6;187(1-3):362-9. doi: 10.1016/j.cbi.2010.02.039. Epub 2010 Mar 19.

4.

Paraoxonase 1, quorum sensing, and P. aeruginosa infection: a novel model.

Estin ML, Stoltz DA, Zabner J.

Adv Exp Med Biol. 2010;660:183-93. doi: 10.1007/978-1-60761-350-3_17.

PMID:
20221881
5.

In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.

Gaidukov L, Bar D, Yacobson S, Naftali E, Kaufman O, Tabakman R, Tawfik DS, Levy-Nissenbaum E.

BMC Clin Pharmacol. 2009 Nov 17;9:18. doi: 10.1186/1472-6904-9-18.

6.

Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes.

Otto TC, Harsch CK, Yeung DT, Magliery TJ, Cerasoli DM, Lenz DE.

Biochemistry. 2009 Nov 3;48(43):10416-22. doi: 10.1021/bi901161b.

7.

Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.

Stevens RC, Suzuki SM, Cole TB, Park SS, Richter RJ, Furlong CE.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12780-4. doi: 10.1073/pnas.0805865105. Epub 2008 Aug 18.

8.

Humanization of antibodies.

Almagro JC, Fransson J.

Front Biosci. 2008 Jan 1;13:1619-33. Review.

PMID:
17981654
9.

Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.

Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM.

Toxicology. 2007 Apr 20;233(1-3):31-9. Epub 2006 Dec 1. Review.

PMID:
17188793
10.

Structure of Pfu Pop5, an archaeal RNase P protein.

Wilson RC, Bohlen CJ, Foster MP, Bell CE.

Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):873-8. Epub 2006 Jan 17.

11.
12.

Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes.

Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS.

Nat Struct Mol Biol. 2004 May;11(5):412-9. Epub 2004 Apr 18. Erratum in: Nat Struct Mol Biol. 2004 Dec;11(12):1253.

PMID:
15098021
13.

Computational design of water-soluble analogues of the potassium channel KcsA.

Slovic AM, Kono H, Lear JD, Saven JG, DeGrado WF.

Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1828-33. Epub 2004 Feb 6.

14.

Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization.

Aharoni A, Gaidukov L, Yagur S, Toker L, Silman I, Tawfik DS.

Proc Natl Acad Sci U S A. 2004 Jan 13;101(2):482-7. Epub 2003 Dec 26.

16.

Pharmacogenetics of paraoxonases: a brief review.

Draganov DI, La Du BN.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Jan;369(1):78-88. Epub 2003 Oct 25. Review.

PMID:
14579013
17.
18.

Computational design of a water-soluble analog of phospholamban.

Slovic AM, Summa CM, Lear JD, DeGrado WF.

Protein Sci. 2003 Feb;12(2):337-48.

19.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk